Don’t miss April’s highlights thanks to our regular monthly round-up of all the most popular stories and resources in the clinical science community
This new solution could enable large-scale AAV vector production for gene therapy
Catch up on all the biggest stories and top downloadable content in the clinical community in our monthly round-up
Scientists from the esteemed Institute for Genetic Medicine, Newcastle, UK, are using sophisticated consumable technologies to advance research into rare mitochondrial diseases
Extended screening service offers novel capabilities for immuno-oncology research in ex vivo T lymphocytes
We asked you how science would change the world in the next 20 years – here's what you said
DNA from 15,000 patients analyzed to identify novel genetic associations
Droplet digital PCR’s effectiveness in detecting minimal residual disease was highlighted by researchers at 60th ASH annual meeting & exposition
New results suggest the MammaTyper test could predict the likelihood of complete pathologic remission
Genomic analysis tools SIRIUS and MERCURY to be implemented into the Google Cloud Platform
We interview a scientist whose team designed AAV vectors used in a successful gene therapy clinical trial, and highlight the key technologies that supported his efforts
Contract researchers and cancer biologists, Robert B. Harris, Ph.D., Thomas Reynolds, and Gregory A. Meyers, owners and founders of NEXT Molecular Analytics, have joined the DNA sequencing revolution. To keep up their research momentum, they consider a next big step — automation
Largest African genetics resource presented at ASHG 2018 annual meeting
Findings reported at ASHG 2018 annual meeting describe new associations between environmental factors and pharmacogenes
Ready-to-use kits determine genomic characteristics of solid tumours
From 3D tissue profiling to intelligent surgical tools, discover some of the latest innovations set to revolutionize diagnostics in cancer
New liquid biopsy test can identify 70 of the most commonly mutated genes in solid tumours, as well as microsatellite instability
Collaborative research effort reduces off-target CRISPR-Cas9 genome editing, removing barriers for human therapeutic applications
Study aims for early detection of pancreatic cancer using blood-based IMMray PanCan-d test
A celebration of the clinical laboratory products that have made the most difference to your lab work, plus we reveal our most popular clinical interviews of the past year
AACC 2018 plenary speaker, Professor James Collins, provides an insight into the future of synthetic biology and CRISPR-based diagnostic tools
SelectScience will be attending the AACC Annual Meeting in Chicago, USA, to interview leading scientists and report on the latest technologies
How scientists at Birmingham Women’s and Children’s Hospital have integrated the latest advancements in clinical mass spectrometry to provide better treatment for serious metabolic disorders
